Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial.

Meijvis SC, Hardeman H, Remmelts HH, Heijligenberg R, Rijkers GT, van Velzen-Blad H, Voorn GP, van de Garde EM, Endeman H, Grutters JC, Bos WJ, Biesma DH.

Lancet. 2011 Jun 11;377(9782):2023-30. doi: 10.1016/S0140-6736(11)60607-7. Epub 2011 Jun 1.

PMID:
21636122
2.

Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial.

Blum CA, Nigro N, Briel M, Schuetz P, Ullmer E, Suter-Widmer I, Winzeler B, Bingisser R, Elsaesser H, Drozdov D, Arici B, Urwyler SA, Refardt J, Tarr P, Wirz S, Thomann R, Baumgartner C, Duplain H, Burki D, Zimmerli W, Rodondi N, Mueller B, Christ-Crain M.

Lancet. 2015 Apr 18;385(9977):1511-8. doi: 10.1016/S0140-6736(14)62447-8. Epub 2015 Jan 19.

3.

Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial.

Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J, Gabarrús A, Sellarés J, Restrepo MI, Anzueto A, Niederman MS, Agustí C.

JAMA. 2015 Feb 17;313(7):677-86. doi: 10.1001/jama.2015.88.

PMID:
25688779
4.

Ceftaroline fosamil versus ceftriaxone for the treatment of Asian patients with community-acquired pneumonia: a randomised, controlled, double-blind, phase 3, non-inferiority with nested superiority trial.

Zhong NS, Sun T, Zhuo C, D'Souza G, Lee SH, Lan NH, Chiang CH, Wilson D, Sun F, Iaconis J, Melnick D.

Lancet Infect Dis. 2015 Feb;15(2):161-71. doi: 10.1016/S1473-3099(14)71018-7. Epub 2014 Dec 22.

PMID:
25539586
5.

Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial.

Asehnoune K, Seguin P, Allary J, Feuillet F, Lasocki S, Cook F, Floch H, Chabanne R, Geeraerts T, Roger C, Perrigault PF, Hanouz JL, Lukaszewicz AC, Biais M, Boucheix P, Dahyot-Fizelier C, Capdevila X, Mahe PJ, Le Maguet P, Paugam-Burtz C, Gergaud S, Plaud B, Constantin JM, Malledant Y, Flet L, Sebille V, Roquilly A; Corti-TC Study Group.

Lancet Respir Med. 2014 Sep;2(9):706-16. doi: 10.1016/S2213-2600(14)70144-4. Epub 2014 Jul 24. Erratum in: Lancet Respir Med. 2014 Sep;2(9):e15.

6.

Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study.

el Moussaoui R, de Borgie CA, van den Broek P, Hustinx WN, Bresser P, van den Berk GE, Poley JW, van den Berg B, Krouwels FH, Bonten MJ, Weenink C, Bossuyt PM, Speelman P, Opmeer BC, Prins JM.

BMJ. 2006 Jun 10;332(7554):1355.

7.

Dexamethasone in community-acquired pneumonia.

Joseph L, Goldberg S, Picard E.

Lancet. 2011 Sep 10;378(9795):980; author reply 981. doi: 10.1016/S0140-6736(11)61441-4. No abstract available.

PMID:
21907856
8.

Dexamethasone in community-acquired pneumonia.

Meybeck A, Turbelin C, Delannoy PY, Olive D, Alfandari S.

Lancet. 2011 Sep 10;378(9795):980; author reply 981. doi: 10.1016/S0140-6736(11)61442-6. No abstract available.

PMID:
21907855
9.

Glucocorticoid treatment in community-acquired pneumonia.

Confalonieri M, Meduri GU.

Lancet. 2011 Jun 11;377(9782):1982-4. doi: 10.1016/S0140-6736(11)60777-0. Epub 2011 Jun 1. No abstract available.

PMID:
21636121
10.

Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study.

Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, Della Porta R, Giorgio C, Blasi F, Umberger R, Meduri GU.

Am J Respir Crit Care Med. 2005 Feb 1;171(3):242-8. Epub 2004 Nov 19.

PMID:
15557131
11.

Biomarkers define the clinical response to dexamethasone in community-acquired pneumonia.

Remmelts HH, Meijvis SC, Heijligenberg R, Rijkers GT, Oosterheert JJ, Bos WJ, Endeman H, Grutters JC, Hoepelman AI, Biesma DH.

J Infect. 2012 Jul;65(1):25-31. doi: 10.1016/j.jinf.2012.03.008. Epub 2012 Mar 9.

PMID:
22410382
12.

The effect of simvastatin on inflammatory cytokines in community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial.

Viasus D, Garcia-Vidal C, Simonetti AF, Dorca J, Llopis F, Mestre M, Morandeira-Rego F, Carratalà J.

BMJ Open. 2015 Jan 6;5(1):e006251. doi: 10.1136/bmjopen-2014-006251.

14.

Dexamethasone in community-acquired pneumonia.

Bharti B, Bharti S.

Lancet. 2011 Sep 10;378(9795):979; author reply 981. doi: 10.1016/S0140-6736(11)61439-6. No abstract available.

PMID:
21907853
15.

Treatment and outcomes of community-acquired pneumonia at Canadian hospitals.

Feagan BG, Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK.

CMAJ. 2000 May 16;162(10):1415-20.

16.

Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial.

van Eijk MM, Roes KC, Honing ML, Kuiper MA, Karakus A, van der Jagt M, Spronk PE, van Gool WA, van der Mast RC, Kesecioglu J, Slooter AJ.

Lancet. 2010 Nov 27;376(9755):1829-37. doi: 10.1016/S0140-6736(10)61855-7. Epub 2010 Nov 4.

PMID:
21056464
17.

Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.

Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, Kanegaye JT, Kovalchin JP, Printz BF, Ramilo O, Burns JC.

Lancet. 2014 May 17;383(9930):1731-8. doi: 10.1016/S0140-6736(13)62298-9. Epub 2014 Feb 24.

PMID:
24572997
18.

Corticosteroid treatment for community-acquired pneumonia--the STEP trial: study protocol for a randomized controlled trial.

Blum CA, Nigro N, Winzeler B, Suter-Widmer I, Schuetz P, Briel M, Bingisser R, Zimmerli W, Ullmer E, Elsaesser H, Tarr P, Wirz S, Thomann R, Hofmann E, Rodondi N, Duplain H, Burki D, Mueller B, Christ-Crain M.

Trials. 2014 Jun 28;15:257. doi: 10.1186/1745-6215-15-257.

19.

Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial.

Snijders D, Daniels JM, de Graaff CS, van der Werf TS, Boersma WG.

Am J Respir Crit Care Med. 2010 May 1;181(9):975-82. doi: 10.1164/rccm.200905-0808OC. Epub 2010 Feb 4.

PMID:
20133929
20.

Can dexamethasone be useful in community-acquired pneumonia?

Fracasso P, Costantino G; Gruppo di Autoformazione Metodologica (GrAM).

Intern Emerg Med. 2012 Feb;7(1):77-8. doi: 10.1007/s11739-011-0733-1. Epub 2011 Nov 25. No abstract available.

PMID:
22116629
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk